Boston Scientific Corp $12.85

up +0.30


22/7/2014 04:01 PM  |  NYSE : BSX  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get BSX Trend Analysis - it has outperformed the S&P 500 by 11%

Partner Headlines

  1. Abbott, St. Jude Top Views, But Stocks Under Pressure

    IBD
  2. Belo Sun Mining: 4 Different Insiders Have Purchased Shares During The ...

    GuruFocus
  3. Diamond Hill Capital Comments on Boston Scientific Corp

    GuruFocus
  4. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  5. Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

    Benzinga
  6. #PreMarket Primer: Monday, June 16: Rebels Seize Another Iraqi City

    Benzinga
  7. #PreMarket Primer: Wednesday, June 11: PBOC Looking For Stable Monetary ...

    Benzinga
  8. UPDATE: Morgan Stanley Reiterates On Boston Scientific On Three Key Debates

    Benzinga
  9. Medical Devices Face Onslaught Of Pricing Pressure

    IBD
  10. Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine ...

    Benzinga
  11. Earnings Scheduled For April 29, 2014

    Benzinga
  12. Boston Scientific Begins Clinical Trial of ACUITY X4 LV Pacing Leads and ...

    Benzinga
  13. St. Jude Medical Earnings In Line, But Stock Falls

    IBD
  14. BOSTON SCIENTIFIC

    IBD
  15. UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of ...

    Benzinga
  16. UPDATE: Bank of America Upgrades Boston Scientific on Multiple Positive ...

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Benzinga's Top Upgrades

    Benzinga
  20. Intuitive Surgical Made Sci-Fi Dreams A Reality

    IBD
  21. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  22. Medtronic, Edwards Face Off For Heart-Device Market

    IBD
  23. Benzinga's Top Upgrades

    Benzinga
  24. Medtronic Earnings Fall, But In Line With Street

    IBD
  25. Boston Scientific sales weak

    IBD
  26. Boston Scientific Q4 Beats, But Stent Sales Weak

    IBD
  27. UPDATE: Boston Scientific Posts Higher Q4 Profit

    Benzinga
  28. Earnings Scheduled For February 4, 2014

    Benzinga
  29. Stocks To Watch For February 4, 2014

    Benzinga
  30. Benzinga's Top Upgrades

    Benzinga
  31. #PreMarket Primer: Tuesday, January 21: China's Central Bank Adds Record ...

    Benzinga
  32. Diamond Hill Capital Comments on Boston Scientific Corp

    GuruFocus
  33. Amaranth Medical Announces Investment from Boston Scientific

    Benzinga
  34. Boston Scientific upgraded

    IBD
  35. Boston Scientific Hits 4-Year High On Double Upgrade

    IBD
  36. Morgan Stanley Upgrades Boston Scientific on Pipeline Acceleration

    Benzinga
  37. #PreMarket Primer: Monday, January 6: Asia Plunges

    Benzinga
  38. No-Dividend Stocks Crushing The Market: Top List

    YCharts
  39. Slideshow: The Top 10 'Highs & Dives' Of S&P 500 Stocks In 2013

    Benzinga
  40. Boston Scientific Receives CE Mark Approval for X4 Quadripolar CRT-D Systems ...

    Benzinga
  41. Market Wrap For December 12: Dow Suffers Second Consecutive Day of Triple ...

    Benzinga
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. UPDATE: FDA Advisory Panel Votes 13-1 on Benefits of Boston Scientific ...

    Benzinga
  44. Stocks Hold Gains, Trade Dips; Retail Stocks Under Pressure

    IBD
  45. 10 Stocks To Be Thankful For This Thanksgiving

    Benzinga
  46. Boston Scientific Receives FDA Approval For Promus Premier Everolimus-Eluting ...

    Benzinga
  47. Boston Scientific Receives FDA Clearance, CE Mark Approval for Direxion ...

    Benzinga
  48. Medtronic Reports Mixed Quarter In Transitional Year

    IBD
  49. Medtronic Q2 Earnings Beat, But Profit Margins Soft

    IBD
  50. Boston Scientific Vercise Deep Brain Stimulation System Receives CE Mark ...

    Benzinga
Trading Center